Search

everythinglearnresearchcommunity

for

Search:↓

Trichotillomania was successfully treated with risperidone and naltrexone.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

TRPV1 affects sebaceous gland function and could help treat acne.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Finasteride reduces opioid use and withdrawal symptoms in animals.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Most patients improved with oral contraceptives, but some needed additional treatment.

A Rathke's cleft cyst caused hormonal imbalances and symptoms in a 68-year-old woman.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Alpha-MSH affects mitochondrial function, and MC1R mutations may increase skin aging.

A woman with severe angioedema improved significantly after treatment with rituximab.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Androgen receptors in the brain affect metabolism and reproduction differently in males and females, and may help manage PCOS symptoms in females.

Certain enzymes react strongly with some hormones in rat skin during hair growth, mainly in sebaceous glands and hair sheaths.

Progesterone reduces anxiety without needing progesterone receptors.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

Drug repurposing shows promise for treating many medical conditions.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

The compounds tested could potentially treat hair loss and alopecia.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.